Clinical Trial

Feasibility Pilot Trial of Med Management in COPD

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A pilot trial to examine feasibility of a pharmacist-led intervention for patients with COPD (Chronic Obstructive Pulmonary Disease) and multimorbidity to improve medication safety and reduce dyspnea. Patients will receive inhaler teaching and medication optimization counseling. Outcomes include feasibility, acceptability, appropriateness, and exploratory measures such as medication discontinuation and patient-reported symptom burden.
Trial Details
NCT Number NCT07453719
Lead Sponsor Duke University
Collaborators: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 92 participants
Start Date 2026-04-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-06